Related Experiment Video
Updated: Jan 10, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Age-Stratified Clinical and Microbiological Profiles in Pediatric Infectious Disease Admissions: Implications for
Cristina Elena Singer1, Elena Catalina Bica1, Simina Gaman2
1Department of Mother and Baby, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Insights
Pediatric infectious disease admissions vary. A composite risk score identified high-risk children needing targeted care, improving antimicrobial stewardship and patient outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Microbiology
Background:
- Pediatric infectious-disease admissions are common but present diverse clinical and microbiological patterns.
- Understanding these patterns is crucial for effective antimicrobial stewardship.
Purpose of the Study:
- To characterize clinical, microbiological, and therapeutic patterns in pediatric infectious-disease admissions.
- To identify high-risk pediatric subgroups for targeted interventions and improved antimicrobial stewardship.
Main Methods:
- An observational cohort study of 136 children stratified by age.
- Data collected included symptoms, diagnoses, culture results, pathogens, antibiotic therapy, and outcomes.
- A composite risk score was developed integrating age, clinical, and microbiological parameters.
Main Results:
- Overall outcomes were favorable, with low intensive care unit (ICU) transfer (8.8%) and mortality (0.7%).
- Pneumonia was the leading diagnosis; *Escherichia coli* and *Klebsiella* species were predominant pathogens.
- A composite risk score effectively identified a high-risk subgroup with increased ICU transfer and prolonged length of stay (LOS).
Conclusions:
- While overall outcomes are good, risk stratification is essential in pediatric infectious diseases.
- An age-stratified, multifactorial assessment aids in identifying at-risk pediatric patients.
- Findings support targeted monitoring and age-aware empiric therapy aligned with antimicrobial stewardship goals.
Abstract:
Background/Objectives: Pediatric infectious-disease admissions are common but heterogeneous. We characterized clinical, microbiological, and therapeutic patterns and identified high-risk subgroups relevant to antimicrobial stewardship. Methods: In an observational cohort of 136 children stratified by age, we recorded symptoms, diagnoses, culture results, pathogens, antibiotic therapy, and outcomes. A composite risk score integrating age and clinical/microbiological parameters was assessed. Results: Outcomes were generally favorable: intensive care unit (ICU) transfer 8.8% (95% confidence interval [CI]: 4.6-15.1), mortality 0.7% (95% CI: 0.1-3.9), and median length of stay (LOS) 10 days (interquartile range [IQR] 8-12). Pneumonia was the leading diagnosis (44.9%; 95% CI: 36.3-53.6). Among isolates, Escherichia coli (47.1%) and Klebsiella species (spp.) (27.9%) predominated. Pneumonia correlated with prolonged LOS (p = 0.006), and gastroenteritis with ICU transfer (p = 0.038) and longer LOS (p = 0.018). Mixed E. coli + Klebsiella infections were linked to prolonged stay (p = 0.021). The composite score identified a high-risk stratum with higher ICU transfer (p = 0.004) and prolonged stay (p = 0.006). Conclusions: Although overall outcomes were favorable, risk was not uniform. An age-stratified, multifactorial assessment-integrating clinical presentation, microbiology, and a composite score-identified pediatric subgroups with worse prognoses, supporting targeted monitoring and stewardship-aligned, age-aware empiric therapy. External validation is warranted.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pharmacokinetics in Pediatric Patients: Drug Distribution